ArticleCureus2026
Uterine Arteriovenous Malformation Associated With Retained Products of Conception Treated by Selective Arterial Embolization: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine arteriovenous malformation is an uncommon but potentially life-threatening cause of abnormal uterine bleeding, particularly after pregnancy-related intrauterine instrumentation. It can mimic or coexist with retained products of conception, and inappropriate curettage may precipitate severe hemorrhage. We report the case of a 27-year-old G1P0 woman who presented with recurrent metrorrhagia, pelvic pain, and two months without a normal menstrual period, five months after an unsupervised termination of pregnancy followed by uterine curettage. She was hemodynamically stable but anemic, with a hemoglobin level of 8.9 g/dL, and serum beta-human chorionic gonadotropin was negative. Transvaginal ultrasonography with color Doppler showed intracavitary material and serpiginous endometrial-myometrial hypervascular channels with turbulent flow. Pelvic magnetic resonance imaging demonstrated posterior myometrial flow voids with early intense enhancement and a dominant arterial supply from the left uterine artery. Pelvic angiography confirmed a high-flow arteriovenous shunt supplied predominantly by the left uterine artery. Selective arterial embolization using absorbable gelatin sponge particles achieved immediate angiographic occlusion of the shunt and clinical control of bleeding. Follow-up ultrasonography at one month showed marked regression, and a six-month examination confirmed complete resolution without recurrent bleeding. This case underscores the importance of considering a uterine vascular lesion in reproductive-age patients with persistent bleeding following pregnancy loss or curettage. Multimodal imaging is essential for distinguishing vascular retained products of conception, enhanced myometrial vascularity, pseudoaneurysm, and uterine arteriovenous malformation. In hemodynamically stable patients desiring future fertility, selective embolization represents an effective fertility-preserving treatment option that avoids the hemorrhagic risks associated with blind curettage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.